Showing results (221-230 of 280) with videos related to

Sort By:
Pageof 28
Journal of Experimental & Clinical Cancer Research : CR|January 13, 2023
Chemotherapy-related hyperbilirubinemia in pediatric acute lymphoblastic leukemia: a genome-wide association study from the AIEOP-BFM ALL study groupStefanie V Junk, Elke Schaeffeler, Martin Zimmermann, et al.
Leukemia|March 14, 2021
Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemiaMartin Stanulla, Elke Schaeffeler, Anja Möricke, et al.
Blood|June 30, 2021
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno ConsortiumSwantje Buchmann, Martin Schrappe, Andre Baruchel, et al.
Blood|July 2, 2011
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 studyMartin Schrappe, Maria Grazia Valsecchi, Claus R Bartram, et al.
Haematologica|October 29, 2017
Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologiesGiovanni Cazzaniga, Paola De Lorenzo, Julia Alten, et al.
Blood|February 21, 2008
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Anja Möricke, Alfred Reiter, Martin Zimmermann, et al.
EMBO Molecular Medicine|November 4, 2018
PDX models recapitulate the genetic and epigenetic landscape of pediatric T-cell leukemiaPaulina Richter-Pechańska, Joachim B Kunz, Beat Bornhauser, et al.
The Lancet. Haematology|July 5, 2023
Dasatinib with intensive chemotherapy in de novo paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (CA180-372/COG AALL1122): a single-arm, multicentre, phase 2 trialStephen P Hunger, Thai Hoa Tran, Vaskar Saha, et al.
Nature Biotechnology|December 25, 2019
Single-cell analysis of structural variations and complex rearrangements with tri-channel processingAshley D Sanders, Sascha Meiers, Maryam Ghareghani, et al.
Hemasphere|August 30, 2023
The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across AgeThomas Beder, Björn-Thore Hansen, Alina M Hartmann, et al.
Pageof 28